Atyr Pharma Overview
Atyr Pharma (LIFE) has a PEG ratio of 28.15, above the Healthcare sector average of 11.64.
Get informed when a big investor buys or sells
+ Follow28.15
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
As of the most recent data, LIFE shows a PEG ratio of 28.15. That is above the Healthcare sector average of 11.64. Scroll down for historical charts and peer comparison views.
The Healthcare sector average PEG ratio is about 11.64. Atyr Pharma is at 28.15, which is higher that average. That is roughly 141.8% above the sector mean. Use the comparison chart on this page to see how LIFE stacks up against individual peers as well.
Investors watch LIFE's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Atyr Pharma's latest reading is 28.15. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this peg ratio page, Stockcircle has Atyr Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently 28.15) with ownership activity and broader fundamentals.
The Healthcare average PEG ratio is about 11.64, while LIFE is at 28.15. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
